Locations
Serving The Global Market
We are proud to operate two advanced sites in China dedicated to ensuring a stable and reliable supply of life-saving medicines to patients worldwide. Both sites and processes are designed to meet global regulatory standards, including NMPA, FDA and EMA.
Suzhou, China
Total Capacity: 60,000L
Located at the heart of a global biomanufacturing hub, our Suzhou facility provides biologics development and clinical- and commercial-scale drug substance and drug product GMP manufacturing.
It holds one of the largest commercialized antibody manufacturing capacities in China at 60,000 liters, and is equipped with international standard process equipment, analytical instruments, HVAC systems, and an online monitoring system.
- 218 Xinghu Street, Unit 101, Building C14
Suzhou Industrial Park
Suzhou, Jiangsu, China
Plant 1
Capacity: 6,000L
6 x 1,000L
Single-Use
Plant 2
Capacity: 18,000L
6 x 3,000L
Stainless Steel
Plant 3
Capacity: 36,000L
12 x 3,000L
Stainless Steel
Quality Control Laboratories
In-process, release and stability testing
Drug Product Fill-Finish
Includes vial and pre-filled syringe filling lines, manual and auto visual inspection, and AI assembly and packaging lines
GMP ADC Facility
GMP manufacturing from conjugation development to final formulation of drug substance
Hangzhou, China
Total Projected Capacity: 172,000L
Our newest mammalian manufacturing facility offers integrated development, large-scale manufacturing of bulk drug substance production with four 20,000-liter bioreactors in operation, and comprehensive drug product services.
The Hangzhou site also offers a standalone ADC & AXC bioconjugation facility, which supports the manufacture of various bioconjugates including high potency ADCs for clinical and commercial supply in both small- and large-scale production.
- 266 Shunfeng Road, Linping District,
Hangzhou, Zhejiang, 311100 China
Plant 1
Capacity: 172,000L
In Operation
4 x 20,000L
Stainless Steel
Under Construction
6 x 2,000L
Single-Use
4 x 20,000L
Stainless Steel
Drug Product Fill-Finish
120 million units annually
Includes vial and pre-filled syringe filling lines, auto visual inspection, and AI assembly and auto packaging lines
ADC & AXC Plant
Drug Substance: 100L-500L, 500L-5,000L*
Drug Product: 2 x 7.5㎡ lyophilizer, 3 x 35㎡ lyophilizer*
(*Under Construction)
Quality Control Laboratories
In-process, release and stability testing
Warehouse
Extensive storage for global distribution
Administration Hall
Home to our innovation center and related administrative functions
Contact
Speak to Our Experts Today
Learn how we can support the manufacture and delivery of your life-changing product.